Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
REGENERX BIOPHARMACEUTICALS INC (RGRX) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/07/2023 8-K Submission of Matters to a Vote of Security Holders, Other Events  Interactive Data
07/10/2023 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E...
Docs: "15245 Shady Grove Road"
11/15/2021 8-K Investor presentation
Docs: "2021 Annual Stockholders Meeting 2 OTCQB: RGRX Forward"
07/22/2021 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Shareholder Letter"
05/14/2021 8-K Quarterly results
03/19/2021 8-K Quarterly results
10/21/2020 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "RegeneRx Closes Convertible Debt Financing"
10/13/2020 8-K Quarterly results
09/30/2019 8-K Quarterly results
03/05/2019 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "RegeneRx Closes $1.3 Million Convertible Debt Financing"
06/15/2018 8-K Submission of Matters to a Vote of Security Holders
04/25/2018 8-K Quarterly results
03/02/2018 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E...
Docs: "RegeneRx Secures $1 Million in Funding"
08/31/2017 8-K Quarterly results
03/13/2017 8-K Form 8-K - Current report
11/01/2016 8-K Submission of Matters to a Vote of Security Holders
09/12/2016 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Presentation Materials"
01/08/2013 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Letter Agreement between the Company and J.J. Finkelstein",
"Letter Agreement between the Company and David R. Crockford",
"Letter Agreement between the Company and Allan L. Goldstein"
11/01/2012 8-K Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits
Docs: "Letter to the Securities and Exchange Commission from Reznick Group, P.C."
10/24/2012 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Form of Convertible Promissory Note",
"Form of Warrant",
"Convertible Note and Warrant Purchase Agreement",
"RegeneRx Issues $300,000 Convertible Note To Pursue Current Initiatives"
07/19/2012 8-K Form 8-K - Current report
07/06/2012 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
03/30/2012 8-K Form 8-K - Current report
01/06/2012 8-K Form 8-K - Current report
12/06/2011 8-K Form 8-K - Current report
08/09/2011 8-K Form 8-K - Current report
08/04/2011 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
03/16/2011 8-K Form 8-K - Current report
01/07/2011 8-K Form 8-K - Current report
12/21/2010 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
11/01/2010 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and...
Docs: "RegeneRx Receives Non-compliance Notice from NYSE Amex; Intends to Request Hearing"
09/02/2010 8-K Form 8-K - Current report
07/20/2010 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "RegeneRx Biopharmaceuticals, Inc. 2010 Equity Incentive Plan",
"Forms of Stock Option Grant Notice and Option Agreement under 2010 Equity Incentive Plan"
07/14/2010 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Management Presentation"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy